drugset / Trial / NCT06238154

Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds

NCT06238154

Phase 4 Completed 40 enrolled Yuzuncu Yil University
RandomizedParallel-groupDouble-blindTreatment

Summary

The amount of active ingredient in tablet form of flurbiprofen is higher than that in the oral spray form. Therefore, based on the hypothesis that the side effects that may occur depending on the dose can be reduced, this clinical study investigated whether tablet and spray form flurbiprofen would have similar effects on postoperative pain in primarily closed soft tissue wounds in the oral region.

Timeline

Start
2023-10-26
Primary completion
2024-01-12
Completion
2024-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Flurbiprofen Small molecule 25 % Oral
Subject Flurbiprofen Small molecule 100 mg Oral

Indications